Research ArticleClinical Investigations
FDG PET Measurement of the Proliferative Potential of Non-Small Cell Lung Cancer
Kotaro Higashi, Yoshimichi Ueda, Masami Yagishita, Yukiko Arisaka, Aya Sakurai, Manabu Oguchi, Hiroyasu Seki, Yoshihiro Nambu, Hisao Tonami and Itaru Yamamoto
Journal of Nuclear Medicine January 2000, 41 (1) 85-92;
Kotaro Higashi
Yoshimichi Ueda
Masami Yagishita
Yukiko Arisaka
Aya Sakurai
Manabu Oguchi
Hiroyasu Seki
Yoshihiro Nambu
Hisao Tonami


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
FDG PET Measurement of the Proliferative Potential of Non-Small Cell Lung Cancer
Kotaro Higashi, Yoshimichi Ueda, Masami Yagishita, Yukiko Arisaka, Aya Sakurai, Manabu Oguchi, Hiroyasu Seki, Yoshihiro Nambu, Hisao Tonami, Itaru Yamamoto
Journal of Nuclear Medicine Jan 2000, 41 (1) 85-92;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Spatial Transcriptomics Reveals Spatially Diverse Cancer-Associated Fibroblast in Lung Squamous Cell Carcinoma Linked to Tumor Progression
- Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events: Demonstration of a Cardiosplenic Axis in Humans
- Outcome Analysis of 18F-Fluorodeoxyglucose Positron-Emission Tomography in Patients with Lung Cancer After Partial Volume Correction
- 4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
- Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery
- 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
- Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
- Fluorine-18-{alpha}-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study
- Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standardized Uptake Value of 2.5
- 18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study
- In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma
- PET in the Assessment of Therapy Response in Patients with Carcinoma of the Head and Neck and of the Esophagus
- Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
- 3-Deoxy-3-[18F]Fluorothymidine-Positron Emission Tomography for Noninvasive Assessment of Proliferation in Pulmonary Nodules
- Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy
- 18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non-Small Cell Lung Cancer
- Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules
- Changing Pattern of Lung Cancer and Its Imaging: 201Tl SPECT Versus [18F]FDG PET